Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (Diluted Average) (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Shares Outstanding (Diluted Average) data on record, last reported at $32.1 million in Q3 2024.

  • For Q3 2024, Shares Outstanding (Diluted Average) rose 424.23% year-over-year to $32.1 million; the TTM value through Sep 2024 reached $32.1 million, up 424.23%, while the annual FY2023 figure was $10.5 million, N/A changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $32.1 million in Q3 2024 per SGMT's latest filing, up from $30.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $32.1 million in Q3 2024 and bottomed at $185137.0 in Q1 2023.